ODF2L expression was also positively related to immune inhibitors, including BTLA, KDR, TGFBR1, and VTCN1 in COAD, and CD274, KDR, VTCN1, and TGFBR1 in READ (p < 0.05, Figure S8B). Here, ODF2L is linked to colon adenocarcinoma.